top of page

PROJECTS

KF VENTURES

FEATURED INVESTMENTS

Herophilus is a neurotherapeutics discovery company based on next-generation scaled complex in vitro models. 

Acquired by Roche, Oct 2023

Tegmine combines mass spectrometry, machine learning, and biology to develop novel targets and highly selective ADCs for oncology.

Waypoint bio

Waypoint uses spatial biology and pooled screening to develop optimized cell therapies.

topos Bio

Mol Dyn meets LLMs.

Onc.AI is a digital health company on a mission to radically improve oncology decision making.

​

DotLab is a women’s healthcare technology company developing a circulating micro RNA blood test to diagnose active endometriosis.

ORB TX

Stealth co.

KF VENTURES

FEATURED INVESTMENTS

Herophilus is a neurotherapeutics discovery company based on next-generation scaled complex in vitro models.

Acquired by Roche, Oct 2023

Onc.AI is a digital health company on a mission to radically improve oncology decision making.

Tegmine combines mass spectrometry, machine learning, and biology to develop highly selective antibody drug targets for oncology.

DotLab is a women’s healthcare technology company developing a circulating micro RNA blood test to diagnose active endometriosis.

Waypoint uses spatial biology and pooled screening to develop optimized cell therapies.

Stealth co.

Mol Dyn meets LLMs.

GET IN TOUCH:

Tel: ‪(415) 340-0839‬

San Francisco, CA 94110

© 2022-5 KF Ventures, LLC

CONTACT US:

Thanks for submitting!

bottom of page